ANTIMICROBIAL RESISTANCE: NEW THREATS AND WAYS TO FIGHT
Keywords:
antimicrobial resistance, antibiotic resistance, drug-resistant infections, multidrug-resistant tuberculosis , antimicrobial stewardship, vaccine development, infection control, global health threat, antiviral resistance, public health policyAbstract
This article explores the growing global health threat of antimicrobial resistance (AMR), highlighting its causes, emerging risks, and the serious implications for public health. It discusses how the overuse and misuse of antibiotics in both human and animal health accelerate the development of resistant pathogens, leading to a future where even common infections could become deadly. The article also examines specific resistant strains, such as multidrug-resistant tuberculosis (MDR-TB), carbapenem-resistant enterobacteriaceae (CRE), and methicillin-resistant Staphylococcus aureus (MRSA), as well as resistance in malaria parasites and viruses. Finally, the article provides an overview of strategies to combat AMR, including antibiotic stewardship, the development of new antibiotics, global surveillance, infection control, and the promotion of vaccination. The collective efforts of governments, healthcare providers, and researchers are essential to tackle this urgent challenge.
Downloads
References
Cohen, M. L., et al. (2019). "The potential consequences of antimicrobial resistance." The Lancet, 392(10150), 2171–2173.
Davies, J., & Davies, D. (2010). "Origins and evolution of antibiotic resistance." Microbiology and Molecular Biology Reviews, 74(3), 417–433.
Gilbert, M., et al. (2019). "Global surveillance of antimicrobial resistance: Methods and applications." Lancet Infectious Diseases, 19(3), 287-296.
Harbarth, S., et al. (2015). "Vaccines: A key to reducing the burden of antimicrobial resistance." Clinical Infectious Diseases, 61(4), 466–473.
Kosmidis, C., et al. (2019). "Carbapenem-resistant Enterobacteriaceae: Recent advances and challenges." Journal of Infection and Chemotherapy, 25(10), 789–796.
Laxminarayan, R., et al. (2013). "Antibiotic resistance—the need for global solutions." The Lancet Infectious Diseases, 13(12), 1057–1098.
O'Neill, J. (2016). "Tackling drug-resistant infections globally: Final report and recommendations." Review on Antimicrobial Resistance.
Smith, R. D., & Coast, J. (2013). "The economic burden of antimicrobial resistance." International Journal of Antimicrobial Agents, 43(5), 391–398.
Tuffrey, S., et al. (2020). "Improving antimicrobial resistance surveillance in low-income countries." Lancet Global Health, 8(5), e658–e660.
van Boeckel, T. P., et al. (2015). "Global antibiotic consumption and resistance: A review of the recent literature." The Lancet Infectious Diseases, 15(10), 1250–1260.
Wright, G. D. (2016). "The antibiotic resistome: The nexus of chemical and genetic diversity." Nature Reviews Microbiology, 14(8), 482–492.
Xu, W., et al. (2018). "The global threat of extensively drug-resistant tuberculosis." Journal of Clinical Tuberculosis and Other Respiratory Infections, 12, 38–47.
World Health Organization (WHO). (2017). "Global Antimicrobial Resistance Surveillance System Report." World Health Organization.
Smith, P. M., et al. (2019). "Understanding the spread of antimicrobial resistance through human, animal, and environmental interactions." Environmental International, 129, 482–493.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in the Journal of Applied Science and Social Science (JASSS) is protected by copyright. Authors retain the copyright to their work, and grant JASSS the right to publish the work under a Creative Commons Attribution License (CC BY). This license allows others to distribute, remix, adapt, and build upon the work, even commercially, as long as they credit the author(s) for the original creation.
